In 2021, the lung-on-chip segment accounted for the highest share in the market, because of the Shor

Falgunimmr10 Jan, 2025Other

has led to a significant number of patient deaths. Thus, the rise in demand to develop laboratory-engineered, functional organs is anticipated to supplement the growth of the market. Recellularized solid organs can perform organ-specific functions for short span of time, which indicates the potential for clinical use of engineered solid organs in the future. Furthermore, the heart-on-chip segment is anticipated to witness the highest growth rate from 2022 to 2029, due to an increase in applications of organ-on-chip devices for the cure of several cardiac diseases such as heart failures.